Upgrade to SI Premium - Free Trial

Brainstorm Cell Therapeutics (BCLI)

1.17 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

BrainStorm Executive Leadership to Participate in DUPHAT 2026; Executive Chairman Peter J. Pitts Invited to Deliver Two Keynote Addresses and Moderate Panel Sessions August 24, 2026 8:16 AM - PR NewsWire Brainstorm Cell Therapeutics (BCLI) Misses Q2 EPS by 6c August 17, 2026 6:32 AM - StreetInsider Form 10-Q BRAINSTORM CELL THERAPEU For: Jun 30 August 14, 2026 4:42 PM - SEC Filing Form 8-K BRAINSTORM CELL THERAPEU For: Aug 14 August 14, 2026 4:24 PM - SEC Filing BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update August 14, 2026 4:00 PM - PR NewsWire Form 8-K BRAINSTORM CELL THERAPEU For: Jul 24 July 30, 2026 4:31 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Jul 24 Filed by: FRENKEL JACOB A July 28, 2026 5:02 PM - SEC Filing Form 4 BRAINSTORM CELL THERAPEU For: Jul 24 Filed by: Pitts Peter Joe July 28, 2026 5:00 PM - SEC Filing BrainStorm names ex-FDA official Peter Pitts as executive chairman July 28, 2026 8:02 AM - StreetInsider BrainStorm Appoints Former FDA Associate Commissioner Peter J. Pitts as Executive Chairman July 28, 2026 8:00 AM - PR NewsWire Full Article List